[Symptomatology and diagnosis of inferior vena cava dysplasias].

The authors analysed the results of examination and dynamic follow up (from 2003 to 2011) of twenty-one 15-to-55-year-old male patients presenting with hypoplasia or aplasia of the inferior vena cava. The diagnosis was verified by means of SCT- or MRT-phlebography. The disease was newly diagnosed at the age of 15-55 years (mean 25.

[Congenital anomalies of the inferior vena cava: diagnosis and medical treatment].

Analyzed herein are the findings obtained following an examination and medical treatment of five 17-to-39-year-old male patients (average age 25.0+/-1.83 years) presenting with congenital abnormalities of the inferior vena cava.

[Deep vein thrombosis as the manifestation of congenital anomaly of inferior vena cava].

Results of examination of 5 male patients aged 20 to 43 years with congenital anomaly of inferior vena cava are analyzed. Complex special examination (CT, MRI, duplex scanning, pelvic phlebography, retrograde cavagraphy) was used for correct diagnosis. Primary treatment of agenesis of inferior vena cava should consist of elastic compression and phlebotonics; in cases of deep vein thrombosis anticoagulants must be used.

[Antiviral properties of various pharmacologic groups of drugs].

Currently used cardiovascular drugs such as nicotinamide, strophanthin, corglycon, curantyl, cavinton, papaverin hydrochloride, nicotinic acid, xantinole nicotinate, isoptin, parmidin and halidor were studied by the program of antiviral drug screening. The majority of them (9 out of 11) were shown to have antiviral activity which was rather individual by its specificity and level. Laboratory strains of 9 viruses inducing the most common infections in man and animals, i.

[The mechanism of the antiviral activity of an antiviral factor of a non-interferon nature].

Antiviral factor (AF) of protein nature has been isolated from chick embryo fibroblasts infected with Venezuelan equine encephalitis virus. The suppression of virus reproduction has been observed both in homologous and heterologous cell cultures when the preparation was introduced immediately after the adsorption of the virus after pretreatment of the cell monolayer. The study has demonstrated that the antiviral effect of AF is not linked with its IFN-alpha and TNF-alpha activity.